224 related articles for article (PubMed ID: 25800176)
1. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
2. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
[TBL] [Abstract][Full Text] [Related]
3. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
[TBL] [Abstract][Full Text] [Related]
4. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
7. Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
Kawaguchi K; Miyake K; Han Q; Li S; Tan Y; Igarashi K; Lwin TM; Higuchi T; Kiyuna T; Miyake M; Oshiro H; Bouvet M; Unno M; Hoffman RM
Cell Cycle; 2018; 17(7):868-873. PubMed ID: 29623758
[TBL] [Abstract][Full Text] [Related]
8. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
[TBL] [Abstract][Full Text] [Related]
9. Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery.
Yano S; Hiroshima Y; Maawy A; Kishimoto H; Suetsugu A; Miwa S; Toneri M; Yamamoto M; Katz MH; Fleming JB; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Cancer Gene Ther; 2015 Jul; 22(7):344-50. PubMed ID: 26088297
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
[TBL] [Abstract][Full Text] [Related]
11. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
[TBL] [Abstract][Full Text] [Related]
13. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
[TBL] [Abstract][Full Text] [Related]
14. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
[TBL] [Abstract][Full Text] [Related]
15. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
[TBL] [Abstract][Full Text] [Related]
16. Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer.
Hiroshima Y; Maawy AA; Katz MH; Fleming JB; Bouvet M; Endo I; Hoffman RM
J Surg Oncol; 2015 Mar; 111(3):311-5. PubMed ID: 25394368
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
Kawaguchi K; Miyake K; Zhao M; Kiyuna T; Igarashi K; Miyake M; Higuchi T; Oshiro H; Bouvet M; Unno M; Hoffman RM
Cell Cycle; 2018; 17(16):2019-2026. PubMed ID: 29963961
[TBL] [Abstract][Full Text] [Related]
18. Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model.
Ogura Y; Mizumoto K; Tanaka M; Ohuchida K; Murakami M; Yamada D; Ishikawa N; Nagai E
Surgery; 2006 Jul; 140(1):66-71. PubMed ID: 16857444
[TBL] [Abstract][Full Text] [Related]
19. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence-guided surgery of human prostate cancer experimental bone metastasis in nude mice using anti-CEA DyLight 650 for tumor illumination.
Miwa S; De Magalhães N; Toneri M; Zhang Y; Cao W; Bouvet M; Tsuchiya H; Hoffman RM
J Orthop Res; 2016 Apr; 34(4):559-65. PubMed ID: 26135883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
